|
||
---|---|---|
Moderator 主持人 | Jianping Liu 刘建平, Wenhua Lin 林文华, Peng Qu 曲鹏, Hengjian Hao 郝恒剑, Jun Guan 管军 | |
8:30 AM- |
Gender Differences in Anticoagulation Therapy for Atrial Fibrillation 房颤抗凝治疗的性别差异 |
Xiling Shou 寿锡凌 |
8:42 AM- |
Scoring Model and Individualized Antithrombotic Therapy 评分模型与抗栓个体化治疗 |
Hongliang Cong 丛洪良 |
8:54 AM- |
Focus on Residual Risks in Hypertensive Patients 关注高血压患者的残余风险 |
Quan Liu 刘全 |
9:06 AM- |
Oral Antithrombotic Strategies in Patients with Atrial Fibrillation after PCI 房颤患者PCI术后的口服抗栓策略 |
Zhenyu Liu 刘震宇 |
9:18 AM- |
Coronary Heart Disease and New Oral Anticoagulant 冠心病与新型口服抗凝剂 |
Genshan Ma 马根山 |
9:30 AM- |
Recognition and Management of High-Risk Patients with Coronary Spasm 高危冠脉痉挛患者的识别和处理 |
Xiangqian Qi 齐向前 |
9:42 AM- |
Timing and Strategy of Antithrombotic Drug Conversion 抗栓药物转换的时机与策略 |
Shouli Wang 王守力 |
9:54 AM- |
Classification of Non-Atherosclerotic Ischemic Heart Disease 再谈非动脉粥样硬化缺血性心脏病的分类 |
Zhiming Yang 杨志明 |
10:06 AM- |
Panel Discussion with Audience Q&A 专家讨论及听众问答 |
|
||
---|---|---|
Moderator 主持人 | Yining Yang 杨毅宁, Luyue Gai 盖鲁粤, Xuewen Qin 秦学文, Daifu Zhang 张代富, Shian Huang 黄石安 | |
10:15 AM- |
Importance and Research of Anticoagulant Therapy in AMI 急性心梗抗凝治疗的地位和研究 |
Lijiang Tang 唐礼江 |
10:27 AM- |
Basic Level Managing Strategy for Hypertention Patients 高血压患者的基层管理策略 |
Guo’an Zhao 赵国安 |
10:39 AM- |
Diagnosis, Prevention, and Management of Contrast-Induced Nephropathy 对比剂肾病的诊断与防治 |
Yuliang Ma 马玉良 |
10:51 AM- |
Diagnosis and Treatment Strategy of Coronary Slow Flow 冠状动脉慢血流的诊疗策略 |
Ping Xie 谢萍 |
11:03 AM- |
Secondary Prevention of ACS Standardization ACS规范化的二级预防 |
Biao Xu 徐标 |
11:15 AM- |
Impact of Sakubastral/Valsartan on Left Ventricular Remodeling in Patients with STEMI 沙库巴曲/缬沙坦对STEMI患者左室重构研究的进展 |
Yanmin Xu 徐延敏 |
11:27 AM- |
Prevention and Treatment of Coronary Microcirculatory Disorder 冠脉微循环障碍的防治 |
Lixia Yang 杨丽霞 |
11:39 AM- |
Role of Adipokines in the Progression of Aoronary atherosclerosis 脂肪因子在冠状动脉粥样硬化进展演变过程的作用 |
Yingxin Zhao 赵迎新 |
11:51 AM- |
Panel Discussion with Audience Q&A 专家讨论及听众问答 |
|
12:00 PM- |
Adjourn 休会 |